Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $72

Benzinga Newsdesk www.benzinga.com Negative 86.7%

Neg 86.7% Neu 0% Pos 0%

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $75 to $72.